Not a member? Become one today

Menu

Data and Systems Committee

Catherine Beaucé (Chair)
Sanofi
France
Rebecca Leyland
AstraZeneca UK
Name TBC
Bayer Healthcare
Germany
Christine Klein
Boehringer Ingelheim GmbH
Germany
Shankar Jesagothy Glaxosmithkline UK
Karen Belentani
Takeda Pharmaceuticals International
Switzerland
Henrik Schwaighofer Fresenius Kabi Germany
Christopher Wooden
IMS Health
France
Jeremy Hillman
IMS Health
UK
Clare McGettigan Kantar Health UK

Objectives

Ensure databases & systems provide the best suitable platform to do international secondary market research through partnership with the major global providers.

Activities

 

  • Regular meetings with core providers like IMS HEALTH to discuss their databases & systems offerings (quality, reliability & service associated) and main development pathways (meet business data requirements, address changing market dynamics or make the best use of latest technologies). They represent a key communication channel between global secondary data providers and international secondary market research functions from pharmaco’s. Secondary data quality & coverage issues are also discussed during those meetings. In that perspective the Committee focus on audits integrated on IMS international databases.
  • Share experiences & best practice in international secondary pharmaceutical market research area using any type of data : sales, medical or promotional.
  • Identify current unmet needs of international pharmaceutical market research.

 

The Committee consists of pharmaceutical international market research representatives and IMS representatives. Project teams may be formed to address specific needs and other providers may be invited to participate whenever appropriate. The Committee always welcomes new members from pharmaceutical industry to enlarge its knowledge & experience sharing.

Members

12 to 15 pharmaco’s members would be the optimum to ensure good coverage of business needs, to maximise the sharing of experiences and to still allow open and constructive discussions with our Committee partnerships with IMS Health.

Membership of Committee is restricted to EphMRA full members, a limit of one member per company. Seniority within a company is not an issue – all we ask is that members have a wide knowledge of IMS data & systems on an international basis (where international means more than 5 countries).

Meetings

The Committee meets twice a year. One meeting is organised within the frame of the yearly EphMRA conference and usually lasts 1.5 days. The second meeting is a one day interim meeting usually taking place in the first quarter of a year. The location for the interim meeting varies depending on the host.

Committee Poster 2015 - Find out more about the Committee's work

Advertise with EphMRA

Web site (home page) banner, eNews adverts and Conference sponsorship/advertising packages are available - all tailored to suit your needs.

Find Out More